Literature DB >> 6282109

Hexamethylmelamine as a single agent in the treatment of small-cell carcinoma of the lung.

H G Goldsweig, F Edgerton, C S Redden, H Takita, J G Garza, H F Bisel.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 6282109     DOI： 10.1097/00000421-198206000-00005

Source DB:  PubMed          Journal:  Am J Clin Oncol        ISSN： 0277-3732            Impact factor:   2.339


× No keyword cloud information.
  3 in total

1.  The bioavailability of three altretamine formulations.

Authors:  E A Runhaar; J P Neijt; J J Holthuis; D de Vos
Journal:  Pharm Weekbl Sci       Date:  1989-12-15

2.  Phase-II study of vindesine and hexamethylmelamine in patients with relapsing small cell carcinoma of the lung.

Authors:  R A Joss; J P Obrecht; W F Jungi; P Alberto; C Sauter; F Cavalli
Journal:  Cancer Chemother Pharmacol       Date:  1984       Impact factor: 3.333

Review 3.  Altretamine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in cancer chemotherapy.

Authors:  C R Lee; D Faulds
Journal:  Drugs       Date:  1995-06       Impact factor: 9.546
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.